JP2004506718A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004506718A5 JP2004506718A5 JP2002521200A JP2002521200A JP2004506718A5 JP 2004506718 A5 JP2004506718 A5 JP 2004506718A5 JP 2002521200 A JP2002521200 A JP 2002521200A JP 2002521200 A JP2002521200 A JP 2002521200A JP 2004506718 A5 JP2004506718 A5 JP 2004506718A5
- Authority
- JP
- Japan
- Prior art keywords
- trifluoromethyl
- methyl
- lower alkyl
- bis
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 40
- 125000000217 alkyl group Chemical group 0.000 claims 39
- -1 cyano, hydroxy Chemical group 0.000 claims 32
- 229910052736 halogen Chemical group 0.000 claims 28
- 150000002367 halogens Chemical group 0.000 claims 28
- 229910052739 hydrogen Inorganic materials 0.000 claims 22
- 239000001257 hydrogen Substances 0.000 claims 22
- 125000003545 alkoxy group Chemical group 0.000 claims 21
- 125000001424 substituent group Chemical group 0.000 claims 19
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 18
- 150000002431 hydrogen Chemical class 0.000 claims 15
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 14
- 125000003118 aryl group Chemical group 0.000 claims 12
- 125000005842 heteroatom Chemical group 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims 7
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 claims 3
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000002464 receptor antagonist Substances 0.000 claims 3
- 229940044551 receptor antagonist Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 229910052740 iodine Inorganic materials 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- NTRWOBLKEGTRRZ-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n,2-dimethyl-n-[4-(2-methylphenyl)-6-(3-oxomorpholin-4-yl)pyridin-3-yl]propanamide Chemical compound C=1N=C(N2C(COCC2)=O)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 NTRWOBLKEGTRRZ-UHFFFAOYSA-N 0.000 claims 1
- POYFDVRKSTZYLN-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[4-(2-chlorophenyl)-6-(3-oxomorpholin-4-yl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(N2C(COCC2)=O)C=C(C=2C(=CC=CC=2)Cl)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 POYFDVRKSTZYLN-UHFFFAOYSA-N 0.000 claims 1
- MZHINWSDMUFLTK-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[4-(2-chlorophenyl)-6-[hydroxy(2-hydroxyethyl)amino]pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(N(O)CCO)C=C(C=2C(=CC=CC=2)Cl)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 MZHINWSDMUFLTK-UHFFFAOYSA-N 0.000 claims 1
- DJHXZQUFUCQSCF-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-(2,5-dioxopyrrolidin-1-yl)-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(N2C(CCC2=O)=O)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 DJHXZQUFUCQSCF-UHFFFAOYSA-N 0.000 claims 1
- PNXNHPPZWZQPFC-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-(3-hydroxyprop-1-ynyl)-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(C#CCO)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 PNXNHPPZWZQPFC-UHFFFAOYSA-N 0.000 claims 1
- QZOBMOMOIREETP-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-(3-methoxyphenyl)sulfinyl-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound COC1=CC=CC(S(=O)C=2N=CC(=C(C=2)C=2C(=CC=CC=2)C)N(C)C(=O)C(C)(C)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C1 QZOBMOMOIREETP-UHFFFAOYSA-N 0.000 claims 1
- YWVBYGXNNDSQKE-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-[(2-hydroxyacetyl)-methylamino]-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C1=NC(N(C(=O)CO)C)=CC(C=2C(=CC=CC=2)C)=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 YWVBYGXNNDSQKE-UHFFFAOYSA-N 0.000 claims 1
- VKGSYQPDZZEVBT-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-[(2-hydroxyacetyl)amino]-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(NC(=O)CO)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 VKGSYQPDZZEVBT-UHFFFAOYSA-N 0.000 claims 1
- MFAORAGGPFAHFN-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-[3-(hydroxymethyl)-1,2-oxazol-5-yl]-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(C=2ON=C(CO)C=2)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 MFAORAGGPFAHFN-UHFFFAOYSA-N 0.000 claims 1
- VPNPPLSEBWZMKS-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-[hydroxy(2-hydroxyethyl)amino]-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(N(O)CCO)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 VPNPPLSEBWZMKS-UHFFFAOYSA-N 0.000 claims 1
- IZARTJCIZPLVHO-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-chloro-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(Cl)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 IZARTJCIZPLVHO-UHFFFAOYSA-N 0.000 claims 1
- YULOPNYEHDHEAK-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-n-[6-ethynyl-4-(2-methylphenyl)pyridin-3-yl]-n,2-dimethylpropanamide Chemical compound C=1N=C(C#C)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 YULOPNYEHDHEAK-UHFFFAOYSA-N 0.000 claims 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 1
- UTGQQKFIXUWNSS-UHFFFAOYSA-N 6-(3-aminoprop-1-ynyl)-n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(C#CCN)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 UTGQQKFIXUWNSS-UHFFFAOYSA-N 0.000 claims 1
- MEPJOJIYUPXTTQ-UHFFFAOYSA-N 6-(5-acetylthiophen-2-yl)-n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(C=2SC(=CC=2)C(C)=O)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 MEPJOJIYUPXTTQ-UHFFFAOYSA-N 0.000 claims 1
- CXOKJILUPIJZNP-UHFFFAOYSA-N [2-[[5-[[2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoyl]-methylamino]-4-(2-methylphenyl)pyridin-2-yl]amino]-2-oxoethyl] acetate Chemical compound C=1N=C(NC(=O)COC(C)=O)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 CXOKJILUPIJZNP-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- WGMLDBIHZUKJDK-UHFFFAOYSA-N methyl 5-[[3,5-bis(trifluoromethyl)phenyl]methyl-methylcarbamoyl]-4-(2-methylphenyl)pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(C=2C(=CC=CC=2)C)=C1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 WGMLDBIHZUKJDK-UHFFFAOYSA-N 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- DNTPKVMGIAQUHB-UHFFFAOYSA-N n-[5-[[2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoyl]-methylamino]-4-(2-methylphenyl)pyridin-2-yl]-n-(cyclopropanecarbonyl)cyclopropanecarboxamide Chemical compound C=1N=C(N(C(=O)C2CC2)C(=O)C2CC2)C=C(C=2C(=CC=CC=2)C)C=1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 DNTPKVMGIAQUHB-UHFFFAOYSA-N 0.000 claims 1
- TWTBZPPWONNSJG-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-(2-hydroxyethylsulfinylmethyl)-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(CS(=O)CCO)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 TWTBZPPWONNSJG-UHFFFAOYSA-N 0.000 claims 1
- AHOSRDROAZBLDX-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-(3-hydroxypropoxy)-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(OCCCO)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 AHOSRDROAZBLDX-UHFFFAOYSA-N 0.000 claims 1
- FLQMVDRONZBQJR-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-(cyanomethyl)-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(CC#N)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 FLQMVDRONZBQJR-UHFFFAOYSA-N 0.000 claims 1
- UIVMYEZJWVDITM-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-(hydroxymethyl)-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(CO)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 UIVMYEZJWVDITM-UHFFFAOYSA-N 0.000 claims 1
- BOMJIRPTWVYTER-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-[4-(2-hydroxyacetyl)piperazin-1-yl]-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(N2CCN(CC2)C(=O)CO)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 BOMJIRPTWVYTER-UHFFFAOYSA-N 0.000 claims 1
- HNZXVWBAYFGNJK-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-[4-(hydroxymethyl)phenyl]-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(C=2C=CC(CO)=CC=2)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 HNZXVWBAYFGNJK-UHFFFAOYSA-N 0.000 claims 1
- DDXRSSAMBKGDNC-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-chloro-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(Cl)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 DDXRSSAMBKGDNC-UHFFFAOYSA-N 0.000 claims 1
- OKFQQNPPMKCZAH-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-6-iodo-n-methyl-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(I)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 OKFQQNPPMKCZAH-UHFFFAOYSA-N 0.000 claims 1
- OYRZRULYKQBKPJ-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-4-(2-methylphenyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)pyridine-3-carboxamide Chemical compound C=1N=C(C=2CCNCC=2)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 OYRZRULYKQBKPJ-UHFFFAOYSA-N 0.000 claims 1
- QICGGICZLHPDGZ-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-4-(2-methylphenyl)-6-(2-methylpyridin-4-yl)pyridine-3-carboxamide Chemical compound C=1N=C(C=2C=C(C)N=CC=2)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 QICGGICZLHPDGZ-UHFFFAOYSA-N 0.000 claims 1
- CMZFMMQINFTXMB-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-4-(2-methylphenyl)-6-pyridin-2-ylsulfinylpyridine-3-carboxamide Chemical compound C=1N=C(S(=O)C=2N=CC=CC=2)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 CMZFMMQINFTXMB-UHFFFAOYSA-N 0.000 claims 1
- KXGXHJWTQFOKTP-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-4-(2-methylphenyl)-6-pyridin-2-ylsulfonylpyridine-3-carboxamide Chemical compound C=1N=C(S(=O)(=O)C=2N=CC=CC=2)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 KXGXHJWTQFOKTP-UHFFFAOYSA-N 0.000 claims 1
- XZJJEHBEFLIGCW-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-4-(2-methylphenyl)-6-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1N=C(C=2C=CN=CC=2)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 XZJJEHBEFLIGCW-UHFFFAOYSA-N 0.000 claims 1
- XIVWYJQCGCJDBA-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-n-methyl-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-4-(2-methylphenyl)pyridine-3-carboxamide Chemical compound C=1N=C(CSC=2N(C=CN=2)C)C=C(C=2C(=CC=CC=2)C)C=1C(=O)N(C)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 XIVWYJQCGCJDBA-UHFFFAOYSA-N 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117003 | 2000-08-08 | ||
| PCT/EP2001/008686 WO2002016324A1 (en) | 2000-08-08 | 2001-07-27 | 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004506718A JP2004506718A (ja) | 2004-03-04 |
| JP2004506718A5 true JP2004506718A5 (en:Method) | 2005-03-03 |
| JP4053877B2 JP4053877B2 (ja) | 2008-02-27 |
Family
ID=8169466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002521200A Expired - Lifetime JP4053877B2 (ja) | 2000-08-08 | 2001-07-27 | ４−フェニル−ピリジン誘導体 |
Country Status (36)
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2208205T3 (es) * | 1999-11-29 | 2004-06-16 | F. Hoffmann-La Roche Ag | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-otolil-piridin-3-il)-isobutiramida. |
| EP1763350B1 (en) * | 2004-07-06 | 2011-12-21 | Xenon Pharmaceuticals Inc. | Nicotinamide derivatives and their use as therapeutic agents |
| BR0313255A (pt) | 2002-08-08 | 2005-07-12 | Amgen Inc | Composto, composição farmacêutica, uso de um composto e métodos de fabricar um medicamento e de preparar um composto |
| EP1688408A3 (en) * | 2002-08-08 | 2007-08-22 | Amgen, Inc | Vanilloid receptor ligands and their use in treatments |
| JP2007521276A (ja) * | 2003-06-25 | 2007-08-02 | スミスクライン・ビーチャム・コーポレイション | Ｎｋ−２およびｎｋ−３として用いるための４−カルボキサミドキノリン誘導体 |
| ES2291891T3 (es) | 2003-07-03 | 2008-03-01 | F. Hoffmann-La Roche Ag | Antagonistas duales de nk1/nk3 para tratamiento de esquizofrenia. |
| MY139645A (en) | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
| WO2005077938A1 (en) | 2004-02-11 | 2005-08-25 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| WO2006002860A1 (en) * | 2004-07-06 | 2006-01-12 | F. Hoffmann-La Roche Ag | Process for preparing carboxamide pyridine derivatives used as intermediates in the synthesis of nk-1 receptor antagonists |
| KR100881240B1 (ko) * | 2004-07-06 | 2009-02-05 | 에프. 호프만-라 로슈 아게 | Ｎｋ-1 수용체 길항제의 합성에 있어서 중간체로서사용되는 카르복스아미드 피리딘 유도체의 제조 방법 |
| US20060030600A1 (en) * | 2004-08-06 | 2006-02-09 | Patrick Schnider | Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia |
| WO2006089311A1 (en) | 2005-02-15 | 2006-08-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| WO2006089674A2 (en) | 2005-02-25 | 2006-08-31 | F.Hoffmann-La Roche Ag | Tablets with improved drug substance dispersibility |
| MX2007012213A (es) * | 2005-04-06 | 2007-12-10 | Hoffmann La Roche | Derivados de piridin-3-carboxamida como agonistas inversos de canabinoides. |
| US20060235028A1 (en) * | 2005-04-14 | 2006-10-19 | Li James J | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
| MX2008002019A (es) * | 2005-08-11 | 2008-04-16 | Vertex Pharma | Moduladores del regulador de conductancia transmembrana de fibrosis quistica. |
| EP1928886B1 (en) | 2005-09-09 | 2011-04-13 | GlaxoSmithKline LLC | Pyridine derivatives and their use in the treatment of psychotic disorders |
| KR101561482B1 (ko) | 2005-11-08 | 2015-10-20 | 버텍스 파마슈티칼스 인코포레이티드 | Ａｔｐ 결합 카세트 수송체의 헤테로사이클릭 조정제 |
| US7671221B2 (en) | 2005-12-28 | 2010-03-02 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| US7645789B2 (en) | 2006-04-07 | 2010-01-12 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| PT2674428T (pt) | 2006-04-07 | 2016-07-14 | Vertex Pharma | Modeladores de transportadores de cassetes de ligação de atp |
| USRE50453E1 (en) | 2006-04-07 | 2025-06-10 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| US7754739B2 (en) | 2007-05-09 | 2010-07-13 | Vertex Pharmaceuticals Incorporated | Modulators of CFTR |
| AU2008208920A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or R(-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an NK1 |
| NZ581259A (en) | 2007-05-09 | 2012-07-27 | Vertex Pharma | Modulators of cystic fibrosis transmembrane conductance regulator |
| UY31272A1 (es) * | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| HUE031913T2 (en) | 2007-12-07 | 2017-08-28 | Vertex Pharma | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| NZ585794A (en) | 2007-12-07 | 2012-05-25 | Vertex Pharma | Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
| ES2647531T3 (es) | 2008-02-28 | 2017-12-22 | Vertex Pharmaceuticals Incorporated | Derivados de heteroarilo como moduladores de CFTR |
| GB0808747D0 (en) | 2008-05-14 | 2008-06-18 | Glaxo Wellcome Mfg Pte Ltd | Novel compounds |
| UA107088C2 (xx) * | 2009-09-11 | 2014-11-25 | 5-(3,4-дихлорфеніл)-n-(2-гідроксициклогексил)-6-(2,2,2-трифторетокси)нікотинамід і його солі як засоби, що підвищують концентрацію лвщ холестерину | |
| WO2011054773A1 (en) | 2009-11-03 | 2011-05-12 | Glaxosmithkline Llc | Novel lactam compounds |
| FR2954315B1 (fr) * | 2009-12-23 | 2012-02-24 | Galderma Res & Dev | Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| ME02446B (me) | 2010-04-07 | 2016-09-20 | Vertex Pharma | Čvrste forme 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksiamido)-3-metilpiridin-2-il)benzoeve kiseline |
| LT3150198T (lt) | 2010-04-07 | 2021-12-10 | Vertex Pharmaceuticals Incorporated | 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il) ciklopropankarboksamido)-3-metilpiridin-2-il)benzoinės rūgšties farmacinė kompozicija ir jos įvedimas |
| JP2013525371A (ja) | 2010-04-22 | 2013-06-20 | バーテックス ファーマシューティカルズ インコーポレイテッド | シクロアルキルカルボキサミド−インドール化合物の製造方法 |
| WO2013049559A1 (en) * | 2011-09-30 | 2013-04-04 | Endo Pharmaceuticals Inc. | Pyridine derivatives |
| US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
| CA2852991C (en) | 2011-11-08 | 2019-12-31 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
| CN108066306B (zh) | 2012-01-25 | 2021-09-07 | 沃泰克斯药物股份有限公司 | 药物制剂及其制备方法 |
| HK1209318A1 (en) | 2012-07-16 | 2016-04-01 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| JP5806420B1 (ja) * | 2013-11-08 | 2015-11-10 | キッセイ薬品工業株式会社 | カルボキシメチルピペリジン誘導体 |
| NZ720958A (en) | 2013-11-12 | 2022-02-25 | Vertex Pharma | Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases |
| HUE039062T2 (hu) | 2014-04-15 | 2018-12-28 | Vertex Pharma | Gyógyszerészeti készítmények cisztás fibrózis transzmembrán konduktancia regulátor által mediált betegségek kezelésére |
| TWI649307B (zh) | 2014-05-07 | 2019-02-01 | 日商橘生藥品工業股份有限公司 | Cyclohexylpyridine derivative |
| PT3221692T (pt) | 2014-11-18 | 2021-09-10 | Vertex Pharma | Processo de realização de testagem de alta produtividade por cromatografia líquida de alta eficiência |
| US10538491B2 (en) * | 2015-03-16 | 2020-01-21 | Vanderbilt University | 4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators |
| EP3393519A1 (en) * | 2015-12-22 | 2018-10-31 | Takeda Pharmaceutical Company Limited | Tripartite modulators of endosomal g protein-coupled receptors |
| US12473260B2 (en) * | 2019-11-15 | 2025-11-18 | KaNDy Therapeutics Limited | Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56106286A (en) | 1980-01-28 | 1981-08-24 | Nippon Musical Instruments Mfg | Electronic musical instrument |
| EP0103545A3 (en) | 1982-09-13 | 1984-10-03 | Arc Technologies Systems, Ltd. | Electrode for arc furnaces |
| US4745123A (en) * | 1986-02-18 | 1988-05-17 | Warner-Lambert Company | Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents |
| PL168236B1 (pl) * | 1990-05-31 | 1996-01-31 | Pfizer | Sposób wytwarzania podstawionych piperydyn PL PL PL |
| IL111960A (en) | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
| CN1067683C (zh) | 1993-12-29 | 2001-06-27 | 默克·夏普-道姆公司 | 取代的吗啉衍生物及其作为治疗剂的用途 |
| TW385308B (en) | 1994-03-04 | 2000-03-21 | Merck & Co Inc | Prodrugs of morpholine tachykinin receptor antagonists |
| DE69628484T2 (de) * | 1995-03-24 | 2004-05-19 | Takeda Chemical Industries, Ltd. | Zyklische Verbindungen, ihre Herstellung und ihre Verwendung als Tachykininrezeptorantagonisten |
| AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
| WO1998021185A1 (en) * | 1996-11-08 | 1998-05-22 | Sankyo Company, Limited | Arylureas or arylmethylcarbamoyl derivatives |
| US5972938A (en) | 1997-12-01 | 1999-10-26 | Merck & Co., Inc. | Method for treating or preventing psychoimmunological disorders |
| HUP0104933A3 (en) * | 1999-01-07 | 2003-12-29 | Warner Lambert Co | Antiviral method using mek inhibitors |
| DK1035115T3 (da) * | 1999-02-24 | 2005-01-24 | Hoffmann La Roche | 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister |
| IL144717A0 (en) * | 1999-02-24 | 2002-06-30 | Hoffmann La Roche | Phenyl-and pyridinyl derivatives |
| EP1222800A2 (en) * | 1999-10-14 | 2002-07-17 | Telefonaktiebolaget LM Ericsson (publ) | System and method of retrieving voice mail messages in a telecommunications network |
| US6303790B1 (en) * | 1999-11-29 | 2001-10-16 | Hoffman-La Roche Inc. | Process for the preparation of pyridine derivatives |
| ES2208205T3 (es) * | 1999-11-29 | 2004-06-16 | F. Hoffmann-La Roche Ag | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-otolil-piridin-3-il)-isobutiramida. |
-
2001
- 2001-07-26 TW TW090118253A patent/TWI259180B/zh not_active IP Right Cessation
- 2001-07-27 NZ NZ523751A patent/NZ523751A/en unknown
- 2001-07-27 ES ES01980219T patent/ES2264706T3/es not_active Expired - Lifetime
- 2001-07-27 RU RU2003105805/04A patent/RU2277087C2/ru not_active IP Right Cessation
- 2001-07-27 BR BR0113173-7A patent/BR0113173A/pt not_active Application Discontinuation
- 2001-07-27 WO PCT/EP2001/008686 patent/WO2002016324A1/en not_active Ceased
- 2001-07-27 KR KR10-2003-7001838A patent/KR100518201B1/ko not_active Expired - Lifetime
- 2001-07-27 CZ CZ2003684A patent/CZ2003684A3/cs unknown
- 2001-07-27 YU YU8703A patent/YU8703A/sh unknown
- 2001-07-27 DE DE60120419T patent/DE60120419T2/de not_active Expired - Lifetime
- 2001-07-27 SI SI200130577T patent/SI1309559T1/sl unknown
- 2001-07-27 DK DK01980219T patent/DK1309559T3/da active
- 2001-07-27 MX MXPA03001143A patent/MXPA03001143A/es active IP Right Grant
- 2001-07-27 AT AT01980219T patent/ATE328871T1/de active
- 2001-07-27 IL IL15407901A patent/IL154079A0/xx active IP Right Grant
- 2001-07-27 JP JP2002521200A patent/JP4053877B2/ja not_active Expired - Lifetime
- 2001-07-27 HR HR20030055A patent/HRP20030055A2/xx not_active Application Discontinuation
- 2001-07-27 HU HU0301671A patent/HUP0301671A3/hu not_active Application Discontinuation
- 2001-07-27 CN CNB018153364A patent/CN1293056C/zh not_active Expired - Lifetime
- 2001-07-27 PT PT01980219T patent/PT1309559E/pt unknown
- 2001-07-27 CA CA002418868A patent/CA2418868C/en not_active Expired - Lifetime
- 2001-07-27 AU AU1211802A patent/AU1211802A/xx active Pending
- 2001-07-27 AU AU2002212118A patent/AU2002212118B2/en not_active Ceased
- 2001-07-27 PL PL35984901A patent/PL359849A1/xx not_active Application Discontinuation
- 2001-07-27 EP EP01980219A patent/EP1309559B1/en not_active Expired - Lifetime
- 2001-08-03 US US09/922,066 patent/US6770637B2/en not_active Expired - Lifetime
- 2001-08-05 JO JO2001130A patent/JO2371B1/en active
- 2001-08-06 MY MYPI20013680A patent/MY128993A/en unknown
- 2001-08-06 PE PE2001000779A patent/PE20020332A1/es not_active Application Discontinuation
- 2001-08-06 PA PA20018524401A patent/PA8524401A1/es unknown
- 2001-08-06 AR ARP010103749A patent/AR030324A1/es not_active Application Discontinuation
- 2001-08-07 UY UY26872A patent/UY26872A1/es not_active Application Discontinuation
- 2001-08-07 GT GT200100160A patent/GT200100160A/es unknown
-
2003
- 2003-01-22 ZA ZA200300614A patent/ZA200300614B/en unknown
- 2003-01-22 IL IL154079A patent/IL154079A/en not_active IP Right Cessation
- 2003-02-05 MA MA27029A patent/MA27680A1/fr unknown
- 2003-02-07 NO NO20030632A patent/NO324841B1/no unknown
- 2003-02-07 EC EC2003004475A patent/ECSP034475A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004506718A5 (en:Method) | ||
| CA2418868A1 (en) | 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists | |
| JP2004504301A5 (en:Method) | ||
| RU2003105805A (ru) | Производные 4-фенилпиридина в качестве антагонистов рецепторов нейрокинина-1 | |
| JP2001526220A5 (en:Method) | ||
| JP5184376B2 (ja) | ベンズアミドおよびヘテロアレーン誘導体 | |
| RU2003102612A (ru) | N-окиси в качестве пролекарств производных 4-фенилпиридина, являющихся натагонистами рецептора nk-1 | |
| JP2018519323A5 (en:Method) | ||
| JP2005501120A5 (en:Method) | ||
| JP2007532651A5 (en:Method) | ||
| WO2005123680B1 (en) | Six-membered heterocycles useful as serine protease inhibitors | |
| JP2004504400A5 (en:Method) | ||
| PH12015502114B1 (en) | 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities | |
| RU2016115803A (ru) | Замещенные никотинимидные ингибиторы втк, их получение и применение в терапии раковых, воспалительных и аутоиммунных заболеваний | |
| RU2010129541A (ru) | Карбоксил- или гидроксилзамещенные производные бензимидазола | |
| JP2007502264A5 (en:Method) | ||
| JP2010538076A5 (en:Method) | ||
| JP2013520473A5 (en:Method) | ||
| JP2010532386A5 (en:Method) | ||
| CA2299139A1 (en) | 4-phenyl-pyridine derivatives | |
| JP2010539110A5 (en:Method) | ||
| JP2005508967A5 (en:Method) | ||
| CA2392570A1 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines | |
| JP2008516902A5 (en:Method) | ||
| CA2416874A1 (en) | 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |